Jasjot Singh has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech's promoters have restructured their shareholding through an off-market deal. Healthy Biosciences Limited (a promoter entity) sold its entire 7.03% stake (1,21,12,174 shares) at Rs. 4.20 per share to two individual promoters. Jasjot Singh acquired 1,00,00,000 shares (5.80%), raising his holding from 11.01% to 16.81%, while Parmjeet Kaur acquired 21,12,174 shares (1.23%), raising hers from 3.30% to 4.52%. The transaction was completed on or after 30th December 2025 and filed with NSE on 31st December 2025. Because the transfer is between members of the same promoter group, the aggregate promoter ownership stays the same and no open offer is triggered.
No change in overall promoter control or voting power since this is a reshuffle within the promoter group. Jasjot Singh emerges as the largest individual promoter with a higher direct stake, which may signal consolidation of ownership in his hands. Share price is unlikely to be materially affected as the deal is internal and at a fixed price.